Journal of Computer-Aided Molecular Design

, Volume 9, Issue 3, pp 251–268 | Cite as

MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry

  • Paul R. Gerber
  • Klaus Müller
Research Papers


The mathematical formulation, parametrization scheme, and structural results of a new, generally applicable molecular force field are presented. The central features are a scheme for automatic parameter assignments, the consistent united-atom approximation, the absence of atom types other than elements, the replacement of electrostatic terms by geometrical hydrogen-bonding terms, the concomitant lack of a need for partial atomic charge assignment and the strict adherence to a finite-range design. As a consequence of omitting all hydrogen atoms, optimal hydrogen-bond patterns are computed dynamically by appropriate network analyses. For a test set of 1589 structures, selected from the Cambridge Structural Database solely on the grounds of a given element list and criteria for high structure refinement, the agreements are on average 2 pm for bonds, 2° for valence angles and 10 to 20 pm for the root-mean-square deviation of atom positions, depending somewhat on size and flexibility of the structures. More qualitative testing of large-scale structural properties of the force field on proteins and DNA oligomers revealed satisfactory performance.


Force field Potential energy function Molecular structure Molecular modelling 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Li, J.H. and Allinger, N.L., J. Comput. Chem., 12 (1991) 186.Google Scholar
  2. 2.
    Brooks, B.R., Bruccoleri, R.E., Olafson, B.D., States, D.J., Swaminathan, S. and Karplus, M., J. Comput. Chem., 4 (1983) 187.Google Scholar
  3. 3.
    Momany, F.A., McGuire, R.F., Burgess, A.W. and Scheraga, H.A., J. Phys. Chem., 79 (1975) 2361.Google Scholar
  4. 4.
    Weiner, S.J., Kollman, P.A., Case, D.A., Singh, U.C., Ghio, C., Alagona, G., ProfetaJr., S. and Weiner, P., J. Am. Chem. Soc., 106 (1984) 765.Google Scholar
  5. 5.
    Van, Gunsteren, W.F. and Berendsen, H.J.C., GROMOS, Biomos, Groningen, 1987.Google Scholar
  6. 6.
    Maple, J.R., Dinur, U. and Hagler, A.T., Proc. Natl. Acad. Sci. USA, 85 (1988) 5350.Google Scholar
  7. 7.
    Clark, M., CramerIII, R.D. and Van, Opdenbosch, N., J. Comput. Chem., 10 (1989) 982.Google Scholar
  8. 8.
    Momany, F.A. and Rone, R., J. Comput. Chem., 13 (1992) 888.Google Scholar
  9. 9.
    Taylor, R. and Kennard, O., J. Am. Chem. Soc., 105 (1983) 5761.Google Scholar
  10. 10.
    Vedani, A. and Dunitz, J.D., J. Am. Chem. Soc., 107 (1985) 7653.Google Scholar
  11. 11.
    Heilbronner, E. and Bock, H., The HMO Model and its Application, Wiley, London, 1976.Google Scholar
  12. 12.
    Trinajstic, N., Chemical Graph Theory, CRC Press, Boca Raton, FL, 1983.Google Scholar
  13. 13.
    Callomon, J.H., Hirota, E., Kuchitsu, K., Lafferty, W.J., Maki, A.G. and Pote, C.S., In Hellwege, K.H. (Ed.) Landolt-Börstein, Vol. 7: Structure Data of Free Polyatomic Molecules, Springer, Berlin, 1976.Google Scholar
  14. 14.
    Allen, F.H., Bellard, S., Brice, M.D., Cartwright, B.A., Doubleday, A., Higgs, H., Hummelink, T., Hummelink-Peters, B.G., Kennard, O., Motherwell, W.D.S., Rogers, J.R. and Watson, D.G., Acta Crystallogr., B35 (1979) 2331.Google Scholar
  15. 15.
    Allred, A.L. and Rochow, E.G., J. Inorg. Nucl. Chem., 5 (1958) 264.Google Scholar
  16. 16.
    Powell, M.J.D., Math. Programming, 12 (1977) 241.Google Scholar
  17. 17.
    Ramanadham, M., Sieker, L.C. and Jensen, L.H., Acta Crystallogr., A37 (1981) 33.Google Scholar
  18. 18.
    Fratini, A.V., Kopka, M.L., Drew, H.R. and Dickerson, R.E., J. Biol. Chem., 257 (1982) 14686.Google Scholar
  19. 19.
    Matthews, D.A., Bolin, J.T., Burridge, J.M., Filman, D.J., Volz, K.W., Kaufman, B.T., Bedell, C.R., Champness, J.N., Stammers, D.K. and Kraut, J., J. Biol. Chem., 260 (1985) 381.Google Scholar

Copyright information

© ESCOM Science Publishers B.V 1995

Authors and Affiliations

  • Paul R. Gerber
    • 1
  • Klaus Müller
    • 1
  1. 1.Pharmaceutical Research and DevelopmentF. Hoffmann-La Roche AGBaselSwitzerland

Personalised recommendations